Leaving BNY Website

 

You are leaving the BNY Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2024 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
 

To learn more about DRs, please contact DRBrokerSolutions@bnymellon.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures (0.42%), Hang Seng Futures (0.43%), ASX SPI 200 +0.44%, S&P Futures +0.08%

Feb 26 ,2025

  • Synopsis:

    • Asian markets set for mixed start to Thursday trade. Futures signaling opening declines in Japan and Hong Kong while ASX higher in initial trade. US contracts unchanged afterhours with NVDA flat following earnings. Australian bonds rallying following latest Treasury curve bull flattening. Canadian dollar and Mexican peso saw knee-jerk gains after Trump flagged another tariff delay, dollar steady elsewhere. Crude up slightly from lows while gold flat and copper steady following earlier rally on Trump tariff threat.

    • NVDA Q4 sales and Q1 guidance both ahead of expectations though revenue and profit growth continued to decelerate, and magnitude of the beat was smaller than previous quarters. Group talked up Blackwell demand and tamped down concerns around production. GM guidance came in soft though anticipates recovery once production fully ramped up. Referencing DeepSeek, expects demand for its chips to remain strong amid AI shift from training to reasoning.

    • Late Wednesday Bloomberg sources reported Beijing intends to begin recapitalizing major banks, Agricultural Bank of China (1288.HK), Bank of Communications (3328.HK) and Postal Savings Bank of China (1658.HK), with injection of at least CNY400B ($55B). Authorities had flagged bank recapitalization plans in 2024 with Bloomberg sources earlier noting up to CNY1T could be injected. Move aimed at shoring up bank balance sheets amid low margin environment, aiding their ability to extend loans and boost economy.

    • Tariff headlines remain volatile after President Trump repeated Canada and Mexico tariffs will proceed with 2-Apr start date, which seemed to contradict proposed early March date. Added that US will also impose 25% tariffs on EU, singling out autos. However, Trump softened his rhetoric on China, refuting reports about investment and curbs and saying he'd welcome Chinese investment in US. Trump also refused to commit to protecting Taiwan from an invasion.

  • Pre-open Company News:

    • 532538.IN -- UltraTech Cement plans to enter wires and cables segment

    • 2196.HK -- Shanghai Fosun Pharma receives NPMA drug registration approval for Tenapanor tablets

    • 6753.JP -- Sharp Corp. reaches settlement with Aleph Electronics (Shenzhen) and Nippon Aleph for ¥500K

    • U10.SP -- UOB-Kay Hian Holdings reports FY net income attributable SG$224.2M, +32% vs year-ago SG$170.4M

    • 688779.CH -- Hunan Changyuan Lico reports preliminary FY net income attributable (CNY502.2M) vs prior guidance (CNY450-600M); year-ago (CNY124.5M)

    • H22.SP -- Hong Leong Asia reports FY net income attributable SG$87.8M, +35% vs year-ago SG$64.9M

    • 2412.TT -- Chunghwa Telecom declares FY24 cash dividend NT$5.0/share; StreetAccnount notes year-ago was NT$4.758/share

    • 603882.CH -- Guangzhou Kingmed Diagnostics Group initiated outperform at Haitong Securities (timing uncertain)

    • 338.HK -- Sinopec Shanghai Petrochemical president Guan Zemin retires, effective immediately

    • 544.SP -- CSE Global reports FY net income attributable SG$26.4M vs year-ago SG$22.5M

    • 9969.HK -- InnoCare Pharma to present data from phase II study of orelabrutinib for RRMS at ACTRIMS

    • 315.HK -- SmarTone Telecommunications Holdings reports H1 net income attributable HK$256.7M, +4% vs year-ago HK$245.8M

    • 1795.TT -- Lotus Pharmaceutical general manager Petar Antonov Vazharov resigns, effective 26-Jun

  • On Deck:

    • China:

      • Earnings:

        • Intchains (ICG)

    • Hong Kong:

      • Earnings:

        • Sun Hung Kai Properties (16.HK), Galaxy Entertainment Group (27.HK), Yixin Group (2858.HK), Hong Kong Exchanges & Clearing (388.HK), Nine Dragons Paper Holdings (2689.HK), China YuHua Education (6169.HK)

    • Japan:

      • Economic:

        • 09:30 JST: Trade Balance NSA (Final); consensus

        • 09:30 JST: Export NSA Y/Y (Final); consensus

        • 09:30 JST: Import NSA Y/Y (Final); consensus

    • Australia:

      • Economic:

        • 11:30 AEST: Capital Expenditure Q/Q; consensus

      • Earnings:

        • Dicker Data (DDR.AU), 5G Networks (5GN.AU), Cromwell Property Group (CMW.AU), Centuria Capital (CNI.AU), Karoon Energy (KAR.AU), Objective Corp. (OCL.AU), WOTSO Property (WOT.AU), Australian Finance Group (AFG.AU), Clinuvel Pharmaceuticals (CUV.AU), Life360 (360.AU), Bubs Australia (BUB.AU), Endeavour Group (EDV.AU), Frontier Digital Ventures (FDV.AU), Fleetwood (FWD.AU), Generation Development Group (GDG.AU), Kina Securities (KSL.AU), Next Science (NXS.AU), Pengana Capital Group (PCG.AU), PEXA Group (PXA.AU), RAM Essential Services Property Fund (REP.AU), Shine Justice (SHJ.AU), Sayona Mining (SYA.AU), TPG Telecom (TPG.AU)

    • New Zealand:

      • Earnings:

        • Delegat Group (DGL.NZ)

    • India:

      • Earnings:

        • KSB Ltd (500249.IN), Sanofi India (500674.IN), Schaeffler India (505790.IN)

    • Malaysia:

      • Earnings:

        • IHH Healthcare (5225.MK)

    • Singapore:

      • Earnings:

        • CapitaLand Investment (9CI.SP), Golden Agri-Resources (E5H.SP), SembCorp Industries (U96.SP), Acrophyte Hospitality Trust (XZL.SP), Bumitama Agri (P8Z.SP), Frencken Group (E28.SP), Indofood Agri Resources (5JS.SP), ComfortDelGro Corp. (C52.SP)

    • Taiwan:

      • Economic:

        • 16:00 TST: GDP NSA Y/Y (Final); consensus +1.8%

      • Earnings:

        • Eclat Textile Co. (1476.TT), Compal Electronics (2324.TT), Yageo (2327.TT), Quanta Computer (2382.TT), Tripod Technology (3044.TT), Taiwan Mobile (3045.TT), Alchip Technologies (3661.TT), The Shanghai Commercial & Savings Bank (5876.TT), Nan Ya Printed Circuit Board (8046.TT)

    • Philippines:

      • Earnings:

        • PLDT Inc (TEL.PM)

  • Market Data:

    • Gold (Apr 25): +$1.50 or +0.05% to $2932.10

    • WTI Crude (Apr 25): +$0.17 or +0.25% to $68.79

    • $-¥: (0.14) or (0.09%) to 148.8870

    • $-KRW: +3.39 or +0.24% to 1434.4200

    • A$-$: (0.00) or (0.52%) to 0.6312

    • $-INR: +0.05 or +0.05% to 87.1786

    • $-CNY: +0.01 or +0.09% to 7.2590

  • If you would like to receive the Asian Market Preview daily, please search for Asia Pre-Market Updates in Alert Manager.

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE